Freenome, Inc.
FRNM- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0002017526
No open-market purchases or sales by Freenome, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $95.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Freenome, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 36 | 36 | 0 |
| Shares | 8.34M | 8.34M | −1.75K (0.0%) |
| Value | $88.6M | $88.4M | −$233.5K (−0.3%) |
New holders (2)
Institutions that held Freenome, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 12,027 | $127.8K | 0.01% |
| Mizuho Securities USA LLC | 10,500 | $110.8K | 0.00% |
Sold out (2)
Institutions that held Freenome, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Fifth Lane Capital, LP | 16,305 | $173.0K |
| Bardin Hill Management Partners LP | 1,159 | $12.3K |